Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Protagonist Therapeutics ( (PTGX) ) is now available.
Daniel N. Swisher Jr. has stepped down from his role on the Board of Directors and the Audit Committee of Protagonist Therapeutics, Inc., effective September 17, 2024, with no reported disagreements regarding company operations. He will remain as an advisor to the company. Following his departure, Sarah A. O’Dowd will join the Audit Committee, and the Board will decrease in size from seven to six members.
For an in-depth examination of PTGX stock, go to TipRanks’ Stock Analysis page.
